Companies / Mirum Pharmaceuticals, Inc. / Activity

Activity — Mirum Pharmaceuticals, Inc.

113 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Perceptive Advisors LLC
13F manager
ExitCommon stock$-20.50M-260K
-100.00%
0
medium
Q4 2025
as of
Norges Bank
13F manager
NewCommon stock$20.79M+263K
263,175
0.41% of shares
medium
Q1 2026
as of
Norges Bank
13F manager
ExitCommon stock$-20.79M-263K
-100.00%
0
medium
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
AddCommon stock$23.39M+253K
+88.56%
539,031
0.83% of shares
medium
Q1 2026
as of
BNP Paribas Financial Markets
13F manager
AddCommon stock$23.62M+256K
+38.98%
911,419
1.40% of shares
medium
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon stock$25.51M+323K
+82.71%
713,452
1.10% of shares
medium
Q1 2026
as of
Arrowstreet Capital, Limited Partnership
13F manager
TrimCommon stock$-28.14M-305K
-81.78%
67,885
0.10% of shares
medium
Q1 2026
as of
RA Capital Management, L.P.
13F manager
NewCommon stock$29.43M+319K
318,554
0.49% of shares
medium
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon stock$35.69M+386K
+99.42%
774,841
1.19% of shares
medium
Q1 2026
as of
Baker Bros. Advisors LP
13F manager
NewCommon stock$41.20M+446K
445,975
0.69% of shares
medium
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
TrimCommon stock$-72.12M-781K
-82.34%
167,489
0.26% of shares
high
Q1 2026
as of
Janus Henderson Group PLC
13F manager
AddCommon stock$81.36M+881K
+14.52%
6,945,813
10.70% of shares
high
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon stock$87.19M+745K
+20.43%
4,390,063
6.76% of shares
high
← PrevPage 3 of 3Next →